Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
Clinical trial NCT06797401 · RECRUITING
Trial details
- NCT number
- NCT06797401
- Sponsor
- Ribocure Pharmaceuticals AB
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-28
- Primary completion
- 2026-05-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.